FDA Warns Abbott To Fix 'Adulterated' Devices

Law360, New York (November 17, 2009, 4:16 PM EST) -- The U.S. Food and Drug Administration has warned Abbott Laboratories to remedy six violations related to its in vitro diagnostic products, describing the devices as adulterated under federal law.

In a letter dated Aug. 12 but not released by the agency until Tuesday, the FDA outlined the six violations at Abbott's diagnostic unit in Des Plaines, Ill.

The violations relate to devices used to diagnose, treat, cure or prevent disease and stem from two FDA investigators' inspection of the Des Plaines facility between June 2 and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.